Sharafudeen Dahiru Abubakar
Overview
Explore the profile of Sharafudeen Dahiru Abubakar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abubakar S, Takaki M, Haeno H
Front Oncol
. 2023 Apr;
13:1116210.
PMID: 37091178
Introduction: Local and regional recurrence after surgical intervention is a significant problem in cancer management. The multistage theory of carcinogenesis precisely places the presence of histologically normal but mutated premalignant...
2.
Ihim S, Abubakar S, Zian Z, Sasaki T, Saffarioun M, Maleknia S, et al.
Front Immunol
. 2022 Aug;
13:919973.
PMID: 36032110
Interleukin-18 (IL-18) is a potent pro-inflammatory cytokine involved in host defense against infections and regulates the innate and acquired immune response. IL-18 is produced by both hematopoietic and non-hematopoietic cells,...
3.
Abubakar S, Ihim S, Farshchi A, Maleknia S, Abdullahi H, Sasaki T, et al.
Immunopharmacol Immunotoxicol
. 2022 Mar;
44(2):147-156.
PMID: 35296212
Primary immunodeficiency diseases (PIDs) consist of a heterogeneous group of genetically disorders that affect distinct components of the immune system. They manifest as increased susceptibility to life-threatening infections, as well...
4.
Abdullahi I, Musa S, Emeribe A, Muhammed M, Mustapha J, Shuwa H, et al.
Biomedicine (Taipei)
. 2022 Feb;
11(1):41-50.
PMID: 35223394
Background: The clinical symptoms, cellular immune response, and serum cytokine homeostasis during falciparum malaria among children living in endemic regions depend on the parasite densities. This study aims to evaluate...
5.
Odigie E, Zakariyya A, Omorodion N, Ogeyehme B, Erameh T, Shema F, et al.
J Infect Dev Ctries
. 2022 Feb;
16(1):49-56.
PMID: 35192521
Medical laboratory personnel encounter diverse health and workplace-related hazards leading to severe health challenges including the ravaging SARS-CoV-2 infection, which is the causal agent of COVID-19. It was first announced...
6.
Emeribe A, Abdullahi I, O R Ajagbe O, Ugwu C, Onoja S, Abubakar S, et al.
Pathog Dis
. 2021 Mar;
79(4).
PMID: 33739369
The 2019 and 2020 sporadic outbreaks of yellow fever (YF) in Sub-Saharan African countries had raised a lot of global health concerns. This article aims to narratively review the vector...
7.
Mustapha J, Abdullahi I, O R Ajagbe O, Emeribe A, Fasogbon S, Onoja S, et al.
Heliyon
. 2021 Jan;
7(1):e05951.
PMID: 33490695
Several months after the emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), cases of re-infection after recovery were reported. The extent and duration of protective immunity after SARS-CoV-2 infection is...
8.
Anka A, Tahir M, Abubakar S, Alsabbagh M, Zian Z, Hamedifar H, et al.
Scand J Immunol
. 2020 Nov;
93(4):e12998.
PMID: 33190302
SARS-CoV-2 is a novel human coronavirus responsible for the Coronavirus disease 2019 (COVID-19) pandemic. Pneumonia and acute respiratory distress syndrome are the major complications of COVID-19. SARS-CoV-2 infection can activate...
9.
Abdullahi I, Emeribe A, Adekola H, Abubakar S, Dangana A, Shuwa H, et al.
Hum Vaccin Immunother
. 2020 Sep;
17(3):620-637.
PMID: 32936732
The incidence and case-fatality rates (CFRs) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the etiological agent for Coronavirus Disease 2019 (COVID-19), have been rising unabated. Even though the...